Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy
Authors
Keywords
-
Journal
Nanoscale
Volume 9, Issue 37, Pages 13879-13904
Publisher
Royal Society of Chemistry (RSC)
Online
2017-09-07
DOI
10.1039/c7nr04959e
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TRAIL–NP hybrids for cancer therapy: a review
- (2017) H. Belkahla et al. Nanoscale
- Will Nanotechnology Bring New Hope for Gene Delivery?
- (2017) Joanna K.L. Wong et al. TRENDS IN BIOTECHNOLOGY
- Polymeric mechanical amplifiers of immune cytokine-mediated apoptosis
- (2017) Michael J. Mitchell et al. Nature Communications
- Multifunctional Nucleus-targeting Nanoparticles with Ultra-high Gene Transfection Efficiency for In Vivo Gene Therapy
- (2017) Ling Li et al. Theranostics
- Improved antitumor activity of TRAIL fusion protein via formation of self-assembling nanoparticle
- (2017) Kaizong Huang et al. Scientific Reports
- Co-delivery of drugs and plasmid DNA for cancer therapy
- (2016) Pei Yun Teo et al. ADVANCED DRUG DELIVERY REVIEWS
- Esterase-Activated Charge-Reversal Polymer for Fibroblast-Exempt Cancer Gene Therapy
- (2016) Nasha Qiu et al. ADVANCED MATERIALS
- Titanium wire implants with nanotube arrays: A study model for localized cancer treatment
- (2016) Gagandeep Kaur et al. BIOMATERIALS
- A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA
- (2016) Cong Luo et al. BIOMATERIALS
- PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer
- (2016) Zhihang Chen et al. BIOMATERIALS
- Super natural killer cells that target metastases in the tumor draining lymph nodes
- (2016) Siddarth Chandrasekaran et al. BIOMATERIALS
- Multifunctional “core-shell” nanoparticles-based gene delivery for treatment of aggressive melanoma
- (2016) Ling Li et al. BIOMATERIALS
- Stem cell-based gene therapy activated using magnetic hyperthermia to enhance the treatment of cancer
- (2016) Perry T. Yin et al. BIOMATERIALS
- Transformable DNA nanocarriers for plasma membrane targeted delivery of cytokine
- (2016) Wujin Sun et al. BIOMATERIALS
- High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumour effect against colon cancer
- (2016) Diego De Miguel et al. CANCER LETTERS
- Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors
- (2016) Lei Miao et al. CANCER RESEARCH
- Onto better TRAILs for cancer treatment
- (2016) D de Miguel et al. CELL DEATH AND DIFFERENTIATION
- Albumin-Based Nanodevices as Drug Carriers
- (2016) Ana Loureiro et al. CURRENT PHARMACEUTICAL DESIGN
- Interactions between carbon nanotubes and bioactives: a drug delivery perspective
- (2016) Neelesh Kumar Mehra et al. DRUG DISCOVERY TODAY
- Findings questioning the involvement of Sigma-1 receptor in the uptake of anisamide-decorated particles
- (2016) Athanasia Dasargyri et al. JOURNAL OF CONTROLLED RELEASE
- Fusion to an albumin-binding domain with a high affinity for albumin extends the circulatory half-life and enhances the in vivo antitumor effects of human TRAIL
- (2016) Rui Li et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy
- (2016) Shengpeng Wang et al. JOURNAL OF CONTROLLED RELEASE
- TRAIL-coated leukocytes that prevent the bloodborne metastasis of prostate cancer
- (2016) Elizabeth C. Wayne et al. JOURNAL OF CONTROLLED RELEASE
- To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
- (2016) F. Danhier JOURNAL OF CONTROLLED RELEASE
- Ligand-targeted theranostic nanomedicines against cancer
- (2016) Virginia J. Yao et al. JOURNAL OF CONTROLLED RELEASE
- Enhanced DR5 binding capacity of nanovectorized TRAIL compared to its cytotoxic version by affinity chromatography and molecular docking studies
- (2016) Albatoul Zakaria et al. JOURNAL OF MOLECULAR RECOGNITION
- Tumor Microenvironment-Mediated Construction and Deconstruction of Extracellular Drug-Delivery Depots
- (2016) Quanyin Hu et al. NANO LETTERS
- Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors
- (2016) Andrew B. Hill et al. TRENDS IN BIOTECHNOLOGY
- Triazine-modified dendrimer for efficient TRAIL gene therapy in osteosarcoma
- (2015) Yu Wang et al. Acta Biomaterialia
- Anticancer Platelet-Mimicking Nanovehicles
- (2015) Quanyin Hu et al. ADVANCED MATERIALS
- Surface-Engineered Dendrimers in Gene Delivery
- (2015) Jiepin Yang et al. CHEMICAL REVIEWS
- Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery
- (2015) Prashant Kesharwani et al. DRUG DISCOVERY TODAY
- Targeting TRAIL in the treatment of cancer: new developments
- (2015) Bora Lim et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer
- (2015) Sun Young Min et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors
- (2015) Yumin Oh et al. JOURNAL OF CONTROLLED RELEASE
- In situ facile-forming PEG cross-linked albumin hydrogels loaded with an apoptotic TRAIL protein
- (2015) Insoo Kim et al. JOURNAL OF CONTROLLED RELEASE
- Vascular-targeted TNFα improves tumor blood vessel function and enhances antitumor immunity and chemotherapy in colorectal cancer
- (2015) Lan Lu et al. JOURNAL OF CONTROLLED RELEASE
- Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer
- (2015) Seong Ho Choi et al. JOURNAL OF CONTROLLED RELEASE
- Nanotechnology approaches for inhalation treatment of lung diseases
- (2015) Andriy Kuzmov et al. JOURNAL OF CONTROLLED RELEASE
- DNA Polyplexes as Combinatory Drug Carriers of Doxorubicin and Cisplatin: An in Vitro Study
- (2015) Han Chang Kang et al. MOLECULAR PHARMACEUTICS
- Nanovectorization of TRAIL with Single Wall Carbon Nanotubes Enhances Tumor Cell Killing
- (2015) Al Batoul Zakaria et al. NANO LETTERS
- Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer
- (2015) Le Quang Thao et al. PHARMACEUTICAL RESEARCH
- Enhancing the antitumor efficacy of a cell-surface death ligand by covalent membrane display
- (2015) Pradeep M. Nair et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma
- (2015) Kui Wang et al. Advanced Healthcare Materials
- Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
- (2015) Rachana Trivedi et al. Frontiers in Oncology
- Sandwich-Type Au-PEI/DNA/PEI-Dexa Nanocomplex for Nucleus-Targeted Gene Delivery in Vitro and in Vivo
- (2014) Zhenzhen Chen et al. ACS Applied Materials & Interfaces
- Gel-Liposome-Mediated Co-Delivery of Anticancer Membrane-Associated Proteins and Small-Molecule Drugs for Enhanced Therapeutic Efficacy
- (2014) Tianyue Jiang et al. ADVANCED FUNCTIONAL MATERIALS
- Furin-Mediated Sequential Delivery of Anticancer Cytokine and Small-Molecule Drug Shuttled by Graphene
- (2014) Tianyue Jiang et al. ADVANCED MATERIALS
- A multicenter, open-label phase II study of recombinant CPT (Circularly Permuted TRAIL) plus thalidomide in patients with relapsed and refractory multiple myeloma
- (2014) Chuanying Geng et al. AMERICAN JOURNAL OF HEMATOLOGY
- DNA Nanoflowers for Multiplexed Cellular Imaging and Traceable Targeted Drug Delivery
- (2014) Rong Hu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Directed Self-Assembly of DNA Tiles into Complex Nanocages
- (2014) Cheng Tian et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Single-Particle Tracking and Modulation of Cell Entry Pathways of a Tetrahedral DNA Nanostructure in Live Cells
- (2014) Le Liang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Structurally engineered anodic alumina nanotubes as nano-carriers for delivery of anticancer therapeutics
- (2014) Ye Wang et al. BIOMATERIALS
- Multi-layered nanoparticles for combination gene and drug delivery to tumors
- (2014) Asiri Ediriwickrema et al. BIOMATERIALS
- Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter
- (2014) Cihui Yan et al. BIOMATERIALS
- Getting TRAIL back on track for cancer therapy
- (2014) J Lemke et al. CELL DEATH AND DIFFERENTIATION
- Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer
- (2014) Joachim von Pawel et al. Clinical Lung Cancer
- Cell-mediated delivery of nanoparticles: Taking advantage of circulatory cells to target nanoparticles
- (2014) Aaron C. Anselmo et al. JOURNAL OF CONTROLLED RELEASE
- sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib
- (2014) M. Loi et al. JOURNAL OF CONTROLLED RELEASE
- Immunoglobulin Fc Domain Fusion to TRAIL Significantly Prolongs Its Plasma Half-Life and Enhances Its Antitumor Activity
- (2014) H. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- TRAIL-coated leukocytes that kill cancer cells in the circulation
- (2014) M. J. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Four-arm PEG cross-linked hyaluronic acid hydrogels containing PEGylated apoptotic TRAIL protein for treating pancreatic cancer
- (2013) Hyeong Jun Byeon et al. Acta Biomaterialia
- Orthogonal Adsorption Onto Nano-Graphene Oxide Using Different Intermolecular Forces for Multiplexed Delivery
- (2013) Feng Wang et al. ADVANCED MATERIALS
- Choline transporter-targeting and co-delivery system for glioma therapy
- (2013) Jianfeng Li et al. BIOMATERIALS
- Doxorubicin-loaded porous PLGA microparticles with surface attached TRAIL for the inhalation treatment of metastatic lung cancer
- (2013) Insoo Kim et al. BIOMATERIALS
- Death receptors as targets in cancer
- (2013) O Micheau et al. BRITISH JOURNAL OF PHARMACOLOGY
- Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family
- (2013) K Azijli et al. CELL DEATH AND DIFFERENTIATION
- Drug delivery by a self-assembled DNA tetrahedron for overcoming drug resistance in breast cancer cells
- (2013) Kyoung-Ran Kim et al. CHEMICAL COMMUNICATIONS
- Nuclear Death Receptor TRAIL-R2 Inhibits Maturation of Let-7 and Promotes Proliferation of Pancreatic and Other Tumor Cells
- (2013) Verena Haselmann et al. GASTROENTEROLOGY
- Safety, pharmacokinetics, and pharmacodynamics of the DR5 antibody LBY135 alone and in combination with capecitabine in patients with advanced solid tumors
- (2013) Sunil Sharma et al. INVESTIGATIONAL NEW DRUGS
- Bioinspired peptides as versatile nucleic acid delivery platforms
- (2013) Vijaya Gopal JOURNAL OF CONTROLLED RELEASE
- Sweeping lymph node micrometastases off their feet: an engineered model to evaluate natural killer cell mediated therapeutic intervention of circulating tumor cells that disseminate to the lymph nodes
- (2013) Siddarth Chandrasekaran et al. LAB ON A CHIP
- APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fc Receptors
- (2013) C. Gieffers et al. MOLECULAR CANCER THERAPEUTICS
- Liposomes Decorated with Apo2L/TRAIL Overcome Chemoresistance of Human Hematologic Tumor Cells
- (2013) Diego De Miguel et al. MOLECULAR PHARMACEUTICS
- Reconstructed Stem Cell Nanoghosts: A Natural Tumor Targeting Platform
- (2013) Naama E. Toledano Furman et al. NANO LETTERS
- Therapeutic efficacy of intravenously administered transferrin-conjugated dendriplexes on prostate carcinomas
- (2013) Majed Al Robaian et al. Nanomedicine
- TRAIL on trial: preclinical advances in cancer therapy
- (2013) Daniel W. Stuckey et al. TRENDS IN MOLECULAR MEDICINE
- Materials innovation for co-delivery of diverse therapeutic cargos
- (2013) Megan E. Godsey et al. RSC Advances
- Surface modification of TPGS-b-(PCL-ran-PGA) nanoparticles with polyethyleneimine as a co-delivery system of TRAIL and endostatin for cervical cancer gene therapy
- (2013) Yi Zheng et al. Nanoscale Research Letters
- Gene and doxorubicin co-delivery system for targeting therapy of glioma
- (2012) Shuhuan Liu et al. BIOMATERIALS
- Intratracheal Administration of a Nanoparticle-Based Therapy with the Angiotensin II Type 2 Receptor Gene Attenuates Lung Cancer Growth
- (2012) A. Kawabata et al. CANCER RESEARCH
- Elevation of c-FLIP in Castrate-Resistant Prostate Cancer Antagonizes Therapeutic Response to Androgen Receptor-Targeted Therapy
- (2012) C. McCourt et al. CLINICAL CANCER RESEARCH
- Protein-based nanocarriers as promising drug and gene delivery systems
- (2012) Ahmed O. Elzoghby et al. JOURNAL OF CONTROLLED RELEASE
- Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo
- (2012) Changyou Zhan et al. JOURNAL OF CONTROLLED RELEASE
- A Death Effector Domain Chain DISC Model Reveals a Crucial Role for Caspase-8 Chain Assembly in Mediating Apoptotic Cell Death
- (2012) Laura S. Dickens et al. MOLECULAR CELL
- Human Umbilical Cord Mesenchymal Stem Cells as Vehicles of CD20-Specific TRAIL Fusion Protein Delivery: A Double-Target Therapy against Non-Hodgkin’s Lymphoma
- (2012) Cihui Yan et al. MOLECULAR PHARMACEUTICS
- Mesenchymal Stem Cells as a Novel Carrier for Targeted Delivery of Gene in Cancer Therapy Based on Nonviral Transfection
- (2012) Yu-Lan Hu et al. MOLECULAR PHARMACEUTICS
- Antitumor effect of human TRAIL on adenoid cystic carcinoma using magnetic nanoparticle–mediated gene expression
- (2012) Leiying Miao et al. Nanomedicine-Nanotechnology Biology and Medicine
- Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
- (2012) Yu Sun et al. NATURE MEDICINE
- Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
- (2012) Hyukjin Lee et al. Nature Nanotechnology
- On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics
- (2012) L Y Dimberg et al. ONCOGENE
- A Logic-Gated Nanorobot for Targeted Transport of Molecular Payloads
- (2012) S. M. Douglas et al. SCIENCE
- Simultaneous Delivery of siRNA and Paclitaxel via a “Two-in-One” Micelleplex Promotes Synergistic Tumor Suppression
- (2011) Tian-Meng Sun et al. ACS Nano
- Micelle-Based Brain-Targeted Drug Delivery Enabled by a Nicotine Acetylcholine Receptor Ligand
- (2011) Changyou Zhan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles
- (2011) Sung Mook Lim et al. BIOMATERIALS
- Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma
- (2011) Shixian Huang et al. BIOMATERIALS
- In vivo treatment of tumors using host-guest conjugated nanoparticles functionalized with doxorubicin and therapeutic gene pTRAIL
- (2011) Hui Fan et al. BIOMATERIALS
- Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types
- (2011) Sungho Bae et al. BIOMATERIALS
- Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey
- (2011) B. B. Aggarwal et al. BLOOD
- Nanoliposome-mediated FL/TRAIL double-gene therapy for colon cancer: In vitro and in vivo evaluation
- (2011) Nian-feng Sun et al. CANCER LETTERS
- Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug
- (2011) Qi-Da Hu et al. CHEMICAL COMMUNICATIONS
- Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer
- (2011) Jean-Charles Soria et al. JOURNAL OF CLINICAL ONCOLOGY
- TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes
- (2011) Liangran Guo et al. JOURNAL OF CONTROLLED RELEASE
- Inorganic nanoparticles for cancer imaging and therapy
- (2011) Huang-Chiao Huang et al. JOURNAL OF CONTROLLED RELEASE
- Impact of albumin on drug delivery — New applications on the horizon
- (2011) Bakheet Elsadek et al. JOURNAL OF CONTROLLED RELEASE
- The use of myristic acid as a ligand of polyethylenimine/DNA nanoparticles for targeted gene therapy of glioblastoma
- (2011) Jin Li et al. NANOTECHNOLOGY
- Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery
- (2011) Jiangbing Zhou et al. NATURE MATERIALS
- Charged for success
- (2011) Enrico Mastrobattista et al. NATURE MATERIALS
- Bio-inspired, bioengineered and biomimetic drug delivery carriers
- (2011) Jin-Wook Yoo et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy
- (2011) Ahmad R. Safa et al. Cancers
- Graphene and Graphene Oxide: Synthesis, Properties, and Applications
- (2010) Yanwu Zhu et al. ADVANCED MATERIALS
- Superior serum half life of albumin tagged TNF ligands
- (2010) Nicole Müller et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer
- (2010) Liang Han et al. BIOMATERIALS
- Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer
- (2010) T Trarbach et al. BRITISH JOURNAL OF CANCER
- Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5)
- (2010) Andres Forero-Torres et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors
- (2010) T. Doi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane
- (2010) Z T Schug et al. CELL DEATH AND DIFFERENTIATION
- A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies
- (2010) D. R. Camidge et al. CLINICAL CANCER RESEARCH
- A First-in-Human Study of Conatumumab in Adult Patients with Advanced Solid Tumors
- (2010) R. S. Herbst et al. CLINICAL CANCER RESEARCH
- Oncogenic K-Ras Turns Death Receptors Into Metastasis-Promoting Receptors in Human and Mouse Colorectal Cancer Cells
- (2010) Frederik J.H. Hoogwater et al. GASTROENTEROLOGY
- Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non–Small-Cell Lung Cancer
- (2010) Jean-Charles Soria et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer
- (2010) Roy S. Herbst et al. JOURNAL OF CLINICAL ONCOLOGY
- PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity
- (2010) Tae Hyung Kim et al. JOURNAL OF CONTROLLED RELEASE
- Preparation and Characterization of Apo2L/TNF-Related Apoptosis-Inducing Ligand–Loaded Human Serum Albumin Nanoparticles with Improved Stability and Tumor Distribution
- (2010) Tae Hyung Kim et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Synergistic Anticancer Effects Achieved by Co-Delivery of TRAIL and Paclitaxel Using Cationic Polymeric Micelles
- (2010) Ashlynn L. Z. Lee et al. MACROMOLECULAR BIOSCIENCE
- Improved Antitumor Activity and Tumor Targeting of NH2-Terminal-Specific PEGylated Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand
- (2010) S. Y. Chae et al. MOLECULAR CANCER THERAPEUTICS
- MS-275 Sensitizes TRAIL-Resistant Breast Cancer Cells, Inhibits Angiogenesis and Metastasis, and Reverses Epithelial-Mesenchymal Transition In vivo
- (2010) R. K. Srivastava et al. MOLECULAR CANCER THERAPEUTICS
- Advancing nonviral gene delivery: lipid- and surfactant-based nanoparticle design strategies
- (2010) McDonald Donkuru et al. Nanomedicine
- Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma
- (2010) S. A. Choi et al. NEURO-ONCOLOGY
- New insights into apoptosis signaling by Apo2L/TRAIL
- (2010) F Gonzalvez et al. ONCOGENE
- Inorganic Nanoparticles in Cancer Therapy
- (2010) Sanjib Bhattacharyya et al. PHARMACEUTICAL RESEARCH
- Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
- (2010) N. Kolishetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Irradiation Enhances the Tumor Tropism and Therapeutic Potential of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Secreting Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Glioma Therapy
- (2010) Seong Muk Kim et al. STEM CELLS
- Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer
- (2009) M. R. Loebinger et al. CANCER RESEARCH
- Specific Targeting of Brain Tumors with an Optical/Magnetic Resonance Imaging Nanoprobe across the Blood-Brain Barrier
- (2009) O. Veiseh et al. CANCER RESEARCH
- Epigenetic Silencing of Death Receptor 4 Mediates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Gliomas
- (2009) A. Elias et al. CLINICAL CANCER RESEARCH
- Cellular FLICE-inhibitory protein (c-FLIP) signalling: A key regulator of receptor-mediated apoptosis in physiologic context and in cancer
- (2009) Marina Bagnoli et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Tumor metastasis and the lymphatic vasculature
- (2009) Jonathan P. Sleeman et al. INTERNATIONAL JOURNAL OF CANCER
- The E3 Ubiquitin Ligase cIAP1 Binds and Ubiquitinates Caspase-3 and -7 via Unique Mechanisms at Distinct Steps in Their Processing
- (2009) Young Eun Choi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment
- (2009) Peter Geserick et al. JOURNAL OF CELL BIOLOGY
- A Combined Chemoimmunotherapy Approach Using a Plasmid−Doxorubicin Complex
- (2009) Vaishali Bagalkot et al. MOLECULAR PHARMACEUTICS
- Development of a Genetically Engineered Biomimetic Vector for Targeted Gene Transfer to Breast Cancer Cells
- (2009) Sriramchandra S. Mangipudi et al. MOLECULAR PHARMACEUTICS
- Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
- (2009) Yogeshkumar Malam et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Nonviral Vectors for Gene Delivery
- (2008) Meredith A. Mintzer et al. CHEMICAL REVIEWS
- Stability and bioactivity of nanocomplex of TNF-related apoptosis-inducing ligand
- (2008) Seong Ju Na et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The Low Density Lipoprotein Receptor-related Protein 1 Mediates Uptake of Amyloid β Peptides in anin VitroModel of the Blood-Brain Barrier Cells
- (2008) Kaoru Yamada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (rhApo2L/TRAIL)
- (2008) Avi Ashkenazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
- (2008) Felix Kratz JOURNAL OF CONTROLLED RELEASE
- Enhancement of antitumor properties of TRAIL by targeted delivery to the tumor neovasculature
- (2008) L. Cao et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation